🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseEfinopegdutide MASH data — July 2024 Page 8

Efinopegdutide MASH data — July 2024

KarenAZ_mom Thu, May 30, 2024 at 2:14 PM 39 replies 2,830 viewsPage 8 of 8
Dr.GastroMayo
VIP Member
2,345
13,456
Jan 2024
Mayo Clinic, MN
Sep 1, 2024 at 12:41 PM#36

Following on from EndoResFellow — and this may be the naive question:

How long did you give it before you decided it was working?

Last edited: Sep 1, 2024 at 5:41 PM
14 12mike_nyc, VendorMark, COA_Karl and 11 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Sep 6, 2024 at 5:18 PM#37
Dr.PulmRoch said:
Keep the original post as written when you update it, and add the correction underneath.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

15 13GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 12 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Sep 11, 2024 at 9:52 PM#38
Dr.PulmRoch said:
Keep the original post as written when you update it, and add the correction underneath.

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

16 14tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 13 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Sep 17, 2024 at 2:23 AM#39
Dr.PulmRoch said:
Keep the original post as written when you update it, and add the correction underneath.

Genuinely useful, thank you. I had the facts and not the framework.

17 15LindaRN_retired, tommy_boulder, hyun_seoul and 14 others
Reply Quote Save Share Report
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Sep 22, 2024 at 6:51 AM#40

From the other side of the consultation, briefly. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Last edited: Sep 22, 2024 at 10:51 AM
39 12SleepFixSam, PurityPaulOR, MaxMetOK and 36 others
Reply Quote Save Share Report
1678

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register